Fitch Reviews U.S. Small Balance CMBS Transactions
NEW YORK--(BUSINESS WIRE)-- Fitch Ratings has taken various actions on 391 classes from 48 U.S. structured finance transactions. The transactions reviewed consisted of 31 Small Balance Commercial (SBC) transactions and 17 transactions sponsored by affiliated entities of Bayview Asset Management, LLC (Bayview). The Bayview transactions include re-securitization and revolving trust transactions primarily collateralized with small-balance commercial and mixed-use loans.
Rating Action Summary:
--299 classes affirmed;
--65 classes upgraded;
--21 classes downgraded;
--Six classes placed on Rating Watch Negative.
A spreadsheet detailing Fitch's rating actions can be found at 'www.fitchratings.com' by performing a title search for 'U.S. Small-Balance CMBS Rating Actions for June 20, 2016'.
KEY RATING DRIVERS
The rating affirmations reflect the stable to improving performance of the collateral. Since the prior review in June 2015 the average serious delinquency rate declined roughly 90 basis points. The upgrades reflect an improvement in the relationship between credit enhancement and expected loss. All of the downgraded classes were previously rated 'CCCsf' or lower, and reflect a higher likelihood of default. Six investment grade classes - all from a single transaction - were placed on Rating Watch Negative due to interest shortfalls reported on the trustee remittance report. The classes are expected to recover full principal under high investment grade stress scenarios.
Since loan level information is generally not available for these transactions, projected losses are derived based on pool-level performance data. The probability of default (PD) assumptions are based on average output from Fitch's U.S. RMBS Loan Loss Model, specific to sector, vintage and delinquency status. The majority of deals reviewed used average model default levels from the Alt-A sector due to similarities with Alt-A loan attributes and performance. Only two transactions used subprime sector averages. Default expectations were generally lower than the prior review due to enhancements made to the U.S. RMBS Loan Loss Model in May 2016, most notably the inclusion of a cure-rate adjustment to the PD.
The base-case loss severity (LS) projections are determined by issuer-level 12-month historical LS averages, and ranged from 65% - 85%. Stressed loss severity assumptions are based off average LS multiples from the U.S. RMBS Loan Loss Model.
Fitch's cash flow analysis assumes prepayment, loss-timing, and servicer advancing behavior consistent with Alt-A sector vintage averages. For transactions where cash flow analysis is not available, Fitch compared the current bond credit enhancement (CE) to the remaining expected pool loss in each rating stress.
RATING SENSITIVITIES
Fitch's analysis includes rating stress scenarios from 'CCCsf' to 'AAAsf'. The 'CCCsf' scenario is intended to be the most-likely base-case scenario. Rating scenarios above 'CCCsf' are increasingly more stressful and less likely to occur. Although many variables are adjusted in the stress scenarios, the primary driver of the loss scenarios is the home price forecast assumption. In the 'Bsf' scenario, Fitch assumes home prices decline 10% below their long-term sustainable level. The home price decline assumption is increased by 5% at each higher rating category up to a 35% decline in the 'AAAsf' scenario.
In addition to increasing mortgage pool losses at each rating category to reflect increasingly stressful economic scenarios, Fitch analyzes various loss-timing, prepayment, loan modification, servicer advancing, and interest rate scenarios as part of the cash flow analysis. Each class is analyzed with 43 different combinations of loss, prepayment and interest rate projections.
Classes currently rated below 'Bsf' are at-risk to default at some point in the future. As default becomes more imminent, bonds currently rated 'CCCsf' and 'CCsf' will migrate towards 'Csf' and eventually 'Dsf'.
The ratings of bonds currently rated 'Bsf' or higher will be sensitive to future mortgage borrower behavior, which historically has been strongly correlated with home price movements. Despite recent positive trends, Fitch currently expects home prices to decline in some regions before reaching a sustainable level. While Fitch's ratings reflect this home price view, the ratings of outstanding classes may be subject to revision to the extent actual home price and mortgage performance trends differ from those currently projected by Fitch.
DUE DILIGENCE USAGE
No third party due diligence was provided or reviewed in relation to this rating action.
Additional information is available at www.fitchratings.com.
U.S. Small-Balance CMBS Rating Actions for June 20, 2016
https://www.fitchratings.com/creditdesk/reports/report_frame.cfm?rpt_id=883989
Applicable Criteria
Counterparty Criteria for Structured Finance and Covered Bonds (pub. 14 May 2014)
https://www.fitchratings.com/creditdesk/reports/report_frame.cfm?rpt_id=744158
Criteria for Interest Rate Stresses in Structured Finance Transactions and Covered Bonds (pub. 17 May 2016)
https://www.fitchratings.com/creditdesk/reports/report_frame.cfm?rpt_id=879815
Criteria for Rating Caps and Limitations in Global Structured Finance Transactions (pub. 16 Jun 2016)
https://www.fitchratings.com/creditdesk/reports/report_frame.cfm?rpt_id=882401
Global Rating Criteria for Single- and Multi-Name Credit-Linked Notes (pub. 08 Mar 2016)
https://www.fitchratings.com/creditdesk/reports/report_frame.cfm?rpt_id=878513
Global Structured Finance Rating Criteria (pub. 06 Jul 2015)
https://www.fitchratings.com/creditdesk/reports/report_frame.cfm?rpt_id=867952
Rating Criteria for U.S. Residential and Small Balance Commercial Mortgage Servicers (pub. 23 Apr 2015)
https://www.fitchratings.com/creditdesk/reports/report_frame.cfm?rpt_id=864368
U.S. RMBS Cash Flow Analysis Criteria (pub. 15 Apr 2016)
https://www.fitchratings.com/creditdesk/reports/report_frame.cfm?rpt_id=880006
U.S. RMBS Loan Loss Model Criteria (pub. 12 May 2016)
https://www.fitchratings.com/creditdesk/reports/report_frame.cfm?rpt_id=880673
U.S. RMBS Master Rating Criteria (pub. 21 Jan 2016)
https://www.fitchratings.com/creditdesk/reports/report_frame.cfm?rpt_id=876378
U.S. RMBS Surveillance and Re-REMIC Criteria (pub. 17 Jun 2016)
https://www.fitchratings.com/creditdesk/reports/report_frame.cfm?rpt_id=881806
Additional Disclosures
Dodd-Frank Rating Information Disclosure Form
https://www.fitchratings.com/creditdesk/press_releases/content/ridf_frame.cfm?pr_id=1007747
Solicitation Status
https://www.fitchratings.com/gws/en/disclosure/solicitation?pr_id=1007747
Endorsement Policy
https://www.fitchratings.com/jsp/creditdesk/PolicyRegulation.faces?context=2&detail=31
ALL FITCH CREDIT RATINGS ARE SUBJECT TO CERTAIN LIMITATIONS AND DISCLAIMERS. PLEASE READ THESE LIMITATIONS AND DISCLAIMERS BY FOLLOWING THIS LINK: HTTP://FITCHRATINGS.COM/UNDERSTANDINGCREDITRATINGS. IN ADDITION, RATING DEFINITIONS AND THE TERMS OF USE OF SUCH RATINGS ARE AVAILABLE ON THE AGENCY'S PUBLIC WEBSITE 'WWW.FITCHRATINGS.COM'. PUBLISHED RATINGS, CRITERIA AND METHODOLOGIES ARE AVAILABLE FROM THIS SITE AT ALL TIMES. FITCH'S CODE OF CONDUCT, CONFIDENTIALITY, CONFLICTS OF INTEREST, AFFILIATE FIREWALL, COMPLIANCE AND OTHER RELEVANT POLICIES AND PROCEDURES ARE ALSO AVAILABLE FROM THE 'CODE OF CONDUCT' SECTION OF THIS SITE. FITCH MAY HAVE PROVIDED ANOTHER PERMISSIBLE SERVICE TO THE RATED ENTITY OR ITS RELATED THIRD PARTIES. DETAILS OF THIS SERVICE FOR RATINGS FOR WHICH THE LEAD ANALYST IS BASED IN AN EU-REGISTERED ENTITY CAN BE FOUND ON THE ENTITY SUMMARY PAGE FOR THIS ISSUER ON THE FITCH WEBSITE.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160620006336/en/
Fitch Ratings
Media Relations
Sandro Scenga, New York,
+1-212-908-0278
[email protected]
or
Surveillance
Analyst
Matthew Shaw, +1-212-908-0218
Associate Director
Fitch
Ratings, Inc.
33 Whitehall Street
New York, NY 10004
or
Committee
Chairperson
Roelof Slump, +1-212-908-0544
Managing Director
Source: Fitch Ratings
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Forgent Power Solutions Announces Pricing of Upsized Public Offering of Class A Common Stock
- Junshi Biosciences Enters Licensing Collaboration with Fosun Wanbang on Roconkibart (IL-17A)
- Abbisko Therapeutics and AstraZeneca Enter a Strategic Collaboration to Conduct the Clinical Trial of Lumipodlin (ABSK043), a First-in-Class Oral PD-L1 Inhibitor, in Combination with TAGRISSO® for NS
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Fitch RatingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share